Human medicines European public assessment report EPAR Scenesse afamelanotide Protoporphyria Erythropoietic Date of authorisation 22122014 Revision 4 Status Authorised

Human medicines European public assessment report (EPAR): Scenesse, afamelanotide, Protoporphyria, Erythropoietic, Date of authorisation: 22/12/2014, Revision: 4, Status: Authorised

07:15 EDT 14 May 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Scenesse, afamelanotide, Protoporphyria, Erythropoietic, Date of authorisation: 22/12/2014, Revision: 4, Status: Authorised

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Scenesse, afamelanotide, Protoporphyria, Erythropoietic, Date of authorisation: 22/12/2014, Revision: 4, Status: Authorised"